APA

Testa L., Bhindi R., Van Gaal W. J., Latini R. A., Pizzocri S., Lanotte S., Biondi Zoccai G. G. L., Valgimigli M., Laudisa M. L., Brambilla N., Banning A. P. & Bedogni F. (20101207). What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel. : QJM : monthly journal of the Association of Physicians.

Chicago

Testa L, Bhindi R, Van Gaal W J, Latini R A, Pizzocri S, Lanotte S, Biondi Zoccai G G L, Valgimigli M, Laudisa M L, Brambilla N, Banning A P and Bedogni F. 20101207. What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel. : QJM : monthly journal of the Association of Physicians.

Harvard

Testa L., Bhindi R., Van Gaal W. J., Latini R. A., Pizzocri S., Lanotte S., Biondi Zoccai G. G. L., Valgimigli M., Laudisa M. L., Brambilla N., Banning A. P. and Bedogni F. (20101207). What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel. : QJM : monthly journal of the Association of Physicians.

MLA

Testa L, Bhindi R, Van Gaal W J, Latini R A, Pizzocri S, Lanotte S, Biondi Zoccai G G L, Valgimigli M, Laudisa M L, Brambilla N, Banning A P and Bedogni F. What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel. : QJM : monthly journal of the Association of Physicians. 20101207.